Analysis of risk factors and prognostic differences in hospital-acquired thrombosis between very preterm infants and moderate to late preterm infants - Scorecard - MDSpire
Advertisement
Analysis of risk factors and prognostic differences in hospital-acquired thrombosis between very preterm infants and moderate to late preterm infants
Clinical Scorecard: Evaluation of Risk Factors and Prognostic Variations in Hospital-Acquired Thrombosis Among Very Preterm and Moderate to Late Preterm Infants
At a Glance
Category
Detail
Condition
Neonatal Venous Thrombosis
Key Mechanisms
Catheter-related thrombosis, maternal anticoagulant use
Target Population
Preterm infants (gestational age <37 weeks)
Care Setting
Neonatal Intensive Care Unit
Key Highlights
Incidence of venous thrombosis in preterm infants is 1.0%
Right lower extremity PICC placement is a significant risk factor
96% of thrombosis cases are associated with central venous catheterisation
40% of patients received pharmacotherapy, mainly nadroparin calcium
98% of infants improved and were discharged after treatment
Guideline-Based Recommendations
Diagnosis
Routine vascular ultrasound can improve detection of asymptomatic thrombosis
Management
Individualised pharmacotherapy based on clinical manifestations and thrombus characteristics
Immediate catheter removal for superficial vein thrombosis without anticoagulation
Monitoring & Follow-up
Long-term follow-up is needed to monitor for late adverse outcomes
Risks
Anticoagulant therapy may increase the risk of bleeding
Patient & Prescribing Data
Preterm infants admitted to NICU
Pharmacotherapy primarily involves nadroparin calcium, with adjustments based on thrombus resolution
Clinical Best Practices
Timely adjustment of abnormal catheter positions to reduce thrombosis risk
Monitoring for thrombus resolution or stabilization before catheter removal
